Impotence and diabetes. Studies of androgenic function in diabetic impotent males.
D015068:17-Ketosteroids / Q000652:urine; D000328:Adult; D000728:Androgens / Q000096:biosynthesis*; D000738:Androsterone / Q000096:biosynthesis; D006063:Chorionic Gonadotropin / Q000494:pharmacology; D003687:Dehydroepiandrosterone / Q000096:biosynthesis; D048909:Diabetes Complications; D003920:Diabetes Mellitus / Q000473:pathology; D004576:Electromyography; D007172:Erectile Dysfunction / Q000209:etiology*; D006801:Humans; D007677:Kidney Function Tests; D007985:Leydig Cells; D008297:Male; D009431:Neural Conduction; D009460:Neurologic Examination; D010264:Paraplegia / Q000150:complications / Q000473:pathology; D011284:Pregnenolone / Q000096:biosynthesis; D011374:Progesterone / Q000096:biosynthesis; D013737:Testis / Q000378:metabolism* / Q000473:pathology; D013739:Testosterone / Q000097:blood; D001743:Urinary Bladder / Q000503:physiopathology
D015068:17-Ketosteroids; D000728:Androgens; D006063:Chorionic Gonadotropin; D013739:Testosterone; D003687:Dehydroepiandrosterone; D011374:Progesterone; D011284:Pregnenolone; D000738:Androsterone